early detection bob moens of skin cancer b2b partnerships

Early Detection of Skin Cancer

Bob MoensB2B Partnerships|

SkinVision BV © 2018

SkinVision

● AI and the early detection of skin cancer

● How does this technology work?

● Clinically validated results

● SkinVision in practice

● Who is using SkinVision?

● How can this technology help to get the patient to the right doctor at the

right?

● How can a GP use SkinVision?


One in five will develop skin cancer


Worried about a spot on your skin


95% sensitive

Sensitivity in 2013

SkinVision BV © 2018Author


SkinVision Smart Camera


SkinVision DLNN


Downloads

Worldwide, iPhone & Android

Skin Checks

Analysed every day

Skin cancer found

Melanoma, BCC and SCC

million Thousand thousand


Video SkinVision Clinical results (Tobias)


● The algorithm scored a 95.1% (95% CI, 91.9–97.3%) sensitivity in detecting (pre)malignant conditions

● The level of sensitivity was achieved with a 78.3% (95% CI, 77.2–79.3%) specificity.

New Research Published

Results


Dermatologists involved (Martijn)


Benefit for all stakeholders

Patient GP Dermatologists Payer


Skin

Vis

ion

B.V

. C

op

yrig

ht

20

19

Working with leading health partnersacross the globe


Together we care.


Driving the SkinVision Team


Where/how to use as General Practitioner?

Patient is worried about

a mole

Patient is worried about

a mole

Patient makes appointment

with you

Patient makes appointment

with you

You see a patient and considers a

referral

You see a patient and considers a

referral


Experience SkinVision yourself

Use the promo code ICTDag2019for 30 days of unlimited access

Valid until December 31, 2019


- [email protected] Cell: +32475558494

mailto:[email protected]

early detection bob moens of skin cancer b2b partnerships

Documents